S-3,4-Diaminobutyric acid 2HCl is a free amino acid derivative classified by its four-carbon backbone bearing two primary amino groups on the side chain, along with a single carboxyl group and an amino functionality consistent with amino acid salts. The molecule is presented as a dihydrochloride, where two chloride counterions associate with the basic amino sites, and the "S-" stereochemical descriptor indicates a defined stereochemistry at the chiral center of the 3,4-substituted framework. In research and peptide chemistry, this salt form supplies a diamino building block for preparing polycationic or crosslinkable amino acid residues, supporting incorporation into chemical probes and peptide analogues where additional side-chain amines provide handles for further derivatization or conjugation.
CAT No: CP05403
CAS No:141318-80-1
Synonyms/Alias:(S)-3,4-Diaminobutyricaciddihydrochloride;141318-80-1;SCHEMBL6420750;CTK8B8273;MolPort-009-198-034;6866AA;ANW-59868;AKOS006283699;AK-33242;KB-60374;S-3,4-diaminobutyricaciddihydrochloride;TC-148613;(S)-3,4-Diaminobutanoicaciddihydrochloride;I14-37347
1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
2. Cationic cell-penetrating peptides are potent furin inhibitors
3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More